Financial News

SHINE Technologies' FDA filing for radioisotope clears way for commercial use

Janesville's SHINE Technologies said Friday that the company had submitted a Drug Master File (DMF) with the U.S. Food and Drug Administration (FDA) for a radioisotope used in cancer treatment.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback